The Continuous Lactate Monitor (CLM) developed in BEAMS lab has published the results from its first clinical study. The study included 6 healthy individuals who underwent intermittent bouts of incremental exercise and compared the CLM to a commercial lactate analyzer. Details of the study and how continuous monitoring of lactate levels can improve the treatment of critically ill and injured people can be found here.
Results from pilot clinical lactate sensor study, published